Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|Biocept Announces Commercial Launch of T...||06/18/19|
|Biocept continues to expand its commercial offering for breast cancer and remains the only liquid biopsy provider to offer single-biomarker testing, t...|
|Biocept to Present at the 9th Annual LD ...||06/03/19|
|SAN DIEGO , June 3, 2019 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physi...|
|Date||2019-03-28 (AMC)||Est. (EPS/Rev.)||($1.58)/ 930K|
|Actual (EPS/Rev.)||$-1.43/ $859.53 K||EPS (TTM)||0|